Funding for this research was provided by:
Kuwait University (YM08/14, SRUL 02/13)
Received: 11 September 2019
Accepted: 27 November 2019
First Online: 5 December 2019
Change Date: 21 April 2020
Change Type: Correction
Change Details: The original publication of this article  contained few erroneous paragraphs and errors in Table��1 and Table��2. The first four paragraphs are in the ���Results��� section while the last four paragraphs are in the ���Discussion��� section. The errors in Table��1 involve the number of isolates tested for pyrazinamide and pyrazinamide susceptible isolates, ethambutol-susceptible isolates with a mutation and number of resistant isolates with a mutation for streptomycin. The error in Table��2 involves wrong codon number for a mutation in isolate KM17-01 in Cluster XII for <i>gidB</i> gene. The updated informations have been indicated in <b>bold</b> and also refer corrected Tables��1 and 2.
Ethics approval and consent to participate
: The study was approved and the need for written informed consent from patients was waived by the Health Sciences Center Ethics Committee, Faculty of Medicine, Kuwait University (Approval No. VDR/EC/2 dated 09-02-2015) and the Ministry of Health, Kuwait.
: Not applicable.
: The authors declare that they have no competing interests.